Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-28
DOI
10.3389/fonc.2021.643065
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LBA25 Results from the phase II biomarker driven trial with nivolumab (N) and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer (m-ccRCC) patients (pts): The BIONIKK trial
- (2020) Y. Vano et al. ANNALS OF ONCOLOGY
- Survivin at a glance
- (2019) Sally P. Wheatley et al. JOURNAL OF CELL SCIENCE
- Tumor cells hijack macrophage-produced complement C1q to promote tumor growth
- (2019) Lubka T. Roumenina et al. Cancer Immunology Research
- Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer
- (2019) Carmine D'Aniello et al. Frontiers in Oncology
- Genetic and metabolic hallmarks of clear cell renal cell carcinoma
- (2018) Danielle J. Sanchez et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
- (2018) Florian Büttner et al. BMC Medicine
- Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
- (2018) Samra Turajlic et al. CELL
- Immune-based identification of cancer patients at high risk of progression
- (2018) Yann-Alexandre Vano et al. CURRENT OPINION IN IMMUNOLOGY
- Prognostic Value of RNASEH2A-, CDK1-, and CD151-Related Pathway Gene Profiling for Kidney Cancers
- (2018) Chin-An Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis
- (2018) Yan-Wei Cao et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient’s overall survival
- (2018) Anica Högner et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Prognostic impact of concomitant loss of PBRM1 and BAP1 protein expression in early stages of clear cell renal cell carcinoma
- (2018) Walter Henriques da Costa et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Fifteen-gene expression based model predicts the survival of clear cell renal cell carcinoma
- (2018) Ping Li et al. MEDICINE
- Genomics and clinical correlates of renal cell carcinoma
- (2018) Thomas J. Mitchell et al. WORLD JOURNAL OF UROLOGY
- Comprehensive assessment gene signatures for clear cell renal cell carcinoma prognosis
- (2018) Peng Chang et al. MEDICINE
- Inflammation and cancer
- (2018) Mariko Murata Environmental Health and Preventive Medicine
- Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma
- (2017) HaiLong Ruan et al. EXPERIMENTAL CELL RESEARCH
- Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma
- (2017) Thai Huu Ho et al. JOURNAL OF CLINICAL ONCOLOGY
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Monitoring immune-checkpoint blockade: response evaluation and biomarker development
- (2017) Mizuki Nishino et al. Nature Reviews Clinical Oncology
- The evolution of anti-angiogenic therapy for kidney cancer
- (2017) Chung-Han Lee et al. Nature Reviews Nephrology
- A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis
- (2017) Bin Liang et al. PLoS One
- Beta-1,4-galactosyltransferase II predicts poor prognosis of patients with non-metastatic clear-cell renal cell carcinoma
- (2017) Haijian Zhang et al. TUMOR BIOLOGY
- Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients
- (2017) Lei Liu et al. BioScience Trends
- Prognostic DNA methylation markers for renal cell carcinoma: a systematic review
- (2017) Sophie C Joosten et al. Epigenomics
- Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review
- (2017) Bum Jun Kim et al. Oncotarget
- Reduced E-cadherin facilitates renal cell carcinoma progression by WNT/β-catenin signaling activation
- (2017) Xinqi Zhang et al. Oncotarget
- Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis
- (2017) Zhichen Pu et al. Oncotarget
- Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma
- (2017) Wei Jiang et al. Oncotarget
- The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry
- (2017) Sung Han Kim et al. PLoS One
- Molecular characterization of clear cell renal cell carcinoma identifies CSNK2A1, SPP1 and DEFB1 as promising novel prognostic markers
- (2016) Maj Rabjerg et al. APMIS
- Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma
- (2016) Magnus Frödin et al. BRITISH JOURNAL OF CANCER
- Cytoplasmic expression of β-catenin is an independent predictor of progression of conventional renal cell carcinoma: a simple immunostaining score
- (2016) Gyula Kovacs et al. HISTOPATHOLOGY
- Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression
- (2016) Richard W. Joseph et al. JOURNAL OF UROLOGY
- Clinicopathological and prognostic significance of survivin expression in renal cancer patients: a meta-analysis
- (2016) Chengquan Ma et al. POSTGRADUATE MEDICAL JOURNAL
- Role of interleukin-6 in cancer progression and therapeutic resistance
- (2016) Neeraj Kumari et al. TUMOR BIOLOGY
- Targeted p21WAF1/CIP1 activation by miR-1236 inhibits cell proliferation and correlates with favorable survival in renal cell carcinoma
- (2016) Chenghe Wang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Loss of nuclear BAP1 protein expression is a marker of poor prognosis in patients with clear cell renal cell carcinoma
- (2016) Daniele Minardi et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma
- (2016) Yuanfeng Yang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Nestin expression on tumour vessels and tumour-infiltrating macrophages define a poor prognosis subgroup of pt1 clear cell renal cell carcinoma
- (2016) Jérôme Cros et al. VIRCHOWS ARCHIV
- Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study
- (2016) A. Ingels et al. WORLD JOURNAL OF UROLOGY
- A four-gene signature predicts survival in clear-cell renal-cell carcinoma
- (2016) Jun Dai et al. Oncotarget
- Elevated expression of IFN-inducible CXCR3 ligands predicts poor prognosis in patients with non-metastatic clear-cell renal cell carcinoma
- (2016) Weisi Liu et al. Oncotarget
- A three-molecule score based on Notch pathway predicts poor prognosis in non-metastasis clear cell renal cell carcinoma
- (2016) Zheng Liu et al. Oncotarget
- CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma
- (2016) Zewei Wang et al. Oncotarget
- Enrichment of C5a-C5aR axis predicts poor postoperative prognosis of patients with clear cell renal cell carcinoma
- (2016) Wei Xi et al. Oncotarget
- Role of IL-2 in cancer immunotherapy
- (2016) Tao Jiang et al. OncoImmunology
- Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma
- (2016) Hana Mlcochova et al. Scientific Reports
- P53 and MDM2 Over-expression and Five-year Survival of Kidney Cancer Patients Undergoing Radical Nephrectomy - Iranian Experience
- (2015) Maryam Abolhasani et al. Asian Pacific Journal of Cancer Prevention
- Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma
- (2015) Li Liu et al. BJU INTERNATIONAL
- Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors
- (2015) Tomasz Wrzesiński et al. BMC CANCER
- Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting
- (2015) B. Beuselinck et al. CLINICAL CANCER RESEARCH
- A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma
- (2015) Yueping Zhan et al. Computational and Mathematical Methods in Medicine
- CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma
- (2015) Huimin An et al. EUROPEAN JOURNAL OF CANCER
- p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma
- (2015) Yu Zhu et al. INTERNATIONAL JOURNAL OF UROLOGY
- Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma
- (2015) Myungsun Shim et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma
- (2015) Yu-Zheng Ge et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies
- (2015) Brian Rini et al. LANCET ONCOLOGY
- Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma
- (2015) Weisi Liu et al. MEDICINE
- Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas
- (2015) Yong Wang et al. TUMOR BIOLOGY
- Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic renal cell carcinoma: Data from the phase III ARISER clinical trial
- (2015) Karim Chamie et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinoma
- (2015) Soo Jeong Nam et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Notch1 Predicts Recurrence and Survival of Patients With Clear-cell Renal Cell Carcinoma After Surgical Resection
- (2015) Huimin An et al. UROLOGY
- Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer
- (2015) Yann Christinat et al. Oncotarget
- Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis
- (2015) Kun Tang et al. Scientific Reports
- Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis
- (2015) Susanne Fuessel et al. BMC CANCER
- Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma
- (2014) Daniel Vergho et al. BMC CANCER
- High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma
- (2014) H An et al. BRITISH JOURNAL OF CANCER
- Expression of vimentin and survivin in clear cell renal cell carcinoma and correlation with p53
- (2014) Z.-G. Shi et al. Clinical & Translational Oncology
- The miR21/10b ratio as a prognostic marker in clear cell renal cell carcinoma
- (2014) Helena K.M. Fritz et al. EUROPEAN JOURNAL OF CANCER
- ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma
- (2014) Samira A. Brooks et al. EUROPEAN UROLOGY
- Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression
- (2014) E. Jason Abel et al. HUMAN PATHOLOGY
- Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma
- (2013) Bishoy A. Gayed et al. BJU INTERNATIONAL
- Polybromo-1 (PBRM1), a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma
- (2013) Walter H. da Costa et al. BJU INTERNATIONAL
- Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma
- (2013) Richard W. Joseph et al. CANCER
- Immunohistochemical Analysis of Prognostic Protein Markers for Primary Localized Clear Cell Renal Cell Carcinoma
- (2013) Thomas Weber et al. CANCER INVESTIGATION
- Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma
- (2013) Naoki Kanomata et al. JOURNAL OF CLINICAL PATHOLOGY
- Prognostic Role of Cell Cycle and Proliferative Biomarkers in Patients with Clear Cell Renal Cell Carcinoma
- (2013) Bishoy A. Gayed et al. JOURNAL OF UROLOGY
- Expression and Prognostic Significance of a Comprehensive Epithelial-Mesenchymal Transition Gene Set in Renal Cell Carcinoma
- (2013) Dong Chen et al. JOURNAL OF UROLOGY
- Dysregulation of β-Catenin is an Independent Predictor of Oncologic Outcomes in Patients with Clear Cell Renal Cell Carcinoma
- (2013) Laura-Maria Krabbe et al. JOURNAL OF UROLOGY
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- Prognostic Value of EZH2 Expression and Activity in Renal Cell Carcinoma: A Prospective Study
- (2013) Li Liu et al. PLoS One
- Deciphering Signatures of Mutational Processes Operative in Human Cancer
- (2013) Ludmil B. Alexandrov et al. Cell Reports
- CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC
- (2012) Swethajit Biswas et al. CARCINOGENESIS
- Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients
- (2012) Michelle A.T. Hildebrandt et al. CARCINOGENESIS
- High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma
- (2012) X.R. Wu et al. EJSO
- Expression and Clinical Significance of Von Hippel-Lindau Downstream Genes: Jade-1 and β-Catenin Related to Renal Cell Carcinoma
- (2012) Xin Lian et al. UROLOGY
- High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma
- (2012) Linhui Wang et al. World Journal of Surgical Oncology
- Immunoexpression Status and Prognostic Value of mTOR and Hypoxia-Induced Pathway Members in Primary and Metastatic Clear Cell Renal Cell Carcinomas
- (2011) Luciana Schultz et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy
- (2011) Aidan P. Noon et al. BJU INTERNATIONAL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The cell cycle and cancer
- (2011) Gareth H Williams et al. JOURNAL OF PATHOLOGY
- Role of Inflammatory Related Gene Expression in Clear Cell Renal Cell Carcinoma Development and Clinical Outcomes
- (2011) Weiqi Tan et al. JOURNAL OF UROLOGY
- Pancreatic metastases from renal cell carcinoma: The state of the art
- (2011) Roberto Ballarin WORLD JOURNAL OF GASTROENTEROLOGY
- Microvessel density and heparanase over-expression in clear cell renal cell cancer: correlations and prognostic significances
- (2011) Juchao Ren et al. World Journal of Surgical Oncology
- Caveolin 1 protein expression in renal cell carcinoma predicts survival
- (2011) Sandra Steffens et al. BMC Urology
- Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
- (2010) Nina Wagener et al. BMC CANCER
- Loss of nuclear p27kip1 and α-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma
- (2010) Alessandro Sgambato et al. CANCER SCIENCE
- Differential role of CD133 and CXCR4 in renal cell carcinoma
- (2010) Crescenzo D’Alterio et al. CELL CYCLE
- Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer
- (2010) C. D'Alterio et al. CURRENT CANCER DRUG TARGETS
- High Jagged1 Expression Predicts Poor Outcome in Clear Cell Renal Cell Carcinoma
- (2010) Kerong Wu et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance
- (2010) Yu Lei et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy
- (2010) Dragomir P Zubac et al. BMC Urology
- Expression of potential molecular markers in renal cell carcinoma: impact on clinicopathological outcomes in patients undergoing radical nephrectomy
- (2009) Iori Sakai et al. BJU INTERNATIONAL
- Development and evaluation of BioScore
- (2009) Alexander S. Parker et al. CANCER
- Molecular Signatures of Localized Clear Cell Renal Cell Carcinoma to Predict Disease-Free Survival after Nephrectomy
- (2009) T. Klatte et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- CD147 and VEGF Expression in Advanced Renal Cell Carcinoma and Their Prognostic Value
- (2009) Yu-Xiang Liang et al. CANCER INVESTIGATION
- Expression Profile of the Polycomb Group Protein Enhancer of Zeste Homologue 2 and its Prognostic Relevance in Renal Cell Carcinoma
- (2009) Stefan Hinz et al. JOURNAL OF UROLOGY
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
- (2009) M. Olivier et al. Cold Spring Harbor Perspectives in Biology
- Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma
- (2008) L Campbell et al. BRITISH JOURNAL OF CANCER
- Survivin Expression in Renal Cell Carcinoma
- (2008) Rosanna Zamparese et al. CANCER INVESTIGATION
- Expression of Heparanase in Renal Cell Carcinomas: Implications for Tumor Invasion and Prognosis
- (2008) S. Mikami et al. CLINICAL CANCER RESEARCH
- Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma
- (2008) Alexander S. Parker et al. HUMAN PATHOLOGY
- Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma
- (2008) Jean-Jacques Patard et al. INTERNATIONAL JOURNAL OF CANCER
- A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma
- (2008) Masahiro Yao et al. INTERNATIONAL JOURNAL OF CANCER
- Immunoreactivity of p27(Kip1), cyclin D3, and Ki67 in conventional renal cell carcinoma
- (2008) Ambrosi Pertia et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study
- (2008) Zheng Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now